Navigation Links
Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists
Date:2/1/2012

search Center; Director, Colorectal Cancer Translational Research Program; and Chair, Ad Interim, Department of Cancer Biology. Dr. Ellis is vice-chair of the NCI Colon Cancer Task Force and serves on 8 editorial boards, including Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research. Dr. Ellis has served in leadership roles in major cancer societies including ASCO, American Association for Cancer Research, and the Society for Surgical Oncology.

Dr. Matthew Kulke is a world expert in neuroendocrine (NET) tumors. He is Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, where he leads the Carcinoid and Neuroendocrine Tumor Program. He has a leadership role in the Cancer and Leukemia Group B (CALGB) Gastrointestinal Cancer Committee, chairs the NCI NET Task Force and NCCN NET guidelines committees, and serves on the executive committee of the North American Neuroendocrine Tumor Society. Dr. Kulke has chaired multiple global pivotal studies exploring new therapies for NET.

About NKP-1339
NKP-1339 is a first-in-class small molecule anti-cancer compound that down-regulates GRP78, a known tumor survival and anti-apoptosis factor. In preclinical studies, NKP-1339 has demonstrated activity against multiple tumor types. In the Phase I trial, antitumor activity was seen against multiple cancers, including NET.

About NKP-2235
NKP-2235 is a first-in-class orally available small molecule that targets the endoplasmic reticulum with a unique pattern of cytotoxicity. NKP-2235 IND has been cleared and a Phase I trial will be initiated shortly.

NKP-1339 and NKP-2235 were discovered by Professor Bernhard Keppler, University of Vienna, Austria.

About Niiki Pharma Inc.
Niiki Pharma (www.niikipharma.com) is a development focused oncology company specializing in first-in-class
'/>"/>

SOURCE Niiki Pharma Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Results
2. Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
3. Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other Anti-Cancer Agents
4. Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- EIP Pharma LLC ( www.eippharma.com ) today announced that ... in Alzheimer,s disease (AD) is underway.  VX-745 is an ... the alpha isoform of the protein enzyme p38 mitogen ... human genetic data demonstrate that inflammation is a major ... the science also indicates the p38 MAPK alpha mechanism ...
(Date:6/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/ssvbft/europe_ultrasound ) ... Devices Market - Growth, Trends And Forecasts (2014 - ... the European market is dominated by the likes of ... and Germany . This ... diseases in these regions. The European Ultrasound ...
(Date:6/2/2015)... 3, 2015 Today, the world,s ... As markets become ever more transparent, the importance of ... recognised long ago. Its maxim of "innovation brings progress ... and digitisation. The company has long been ... of the art" technology and modern approach, while also ...
Breaking Medicine Technology:EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3European Ultrasound Devices Market Report 2015-2019 2
... Nov. 4, 2011,   A unique treatment involving the ... John Hospital and Medical Center. SJH&MC is the first ... 20 centers nationwide to offer the treatment. ... has applications for a number of advanced cancers that ...
... 4, 2011   Research led by St. Jude Children,s Research ... protein interactions that are the workhorses of cells and, ... development target. The discovery involves a chemical ... of human proteins have this chemical added to the ...
Cached Medicine Technology:St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System 2Molecule Serves as a Key in Some Protein Interactions 2Molecule Serves as a Key in Some Protein Interactions 3
(Date:6/3/2015)... (PRWEB) June 03, 2015 Implant design ... the osseointegration processes that unites bone to an implant ... portion has been designed to encourage bone regeneration, resulting ... support of stable surrounding soft tissues for more esthetic ... Ginat, Product Manager at MIS Implants. The triangular neck ...
(Date:6/3/2015)... DailyEndorphin is pleased to announce the launch of ... highly configurable new offering, DE's annual clients may now ... its wellness programming for the entire year as a ... new module, annual clients may also do the following: ... (3) Continually report on participant progress towards the stated ...
(Date:6/3/2015)... “ Scanalytics ” was featured on ... features the latest and coolest technology products available to ... of NewsWatch, conducted the review and shared with viewers ... in retail stores. , Tracking statistics in business is ... comes to retail this goes a step beyond revenue ...
(Date:6/3/2015)... Chino Hills, Calif. (PRWEB) June 03, 2015 ... and most popular boot camp fitness program. The company helps ... happier, healthier lives. To encourage more people to hit the ... has released these five tips for getting the most out ... Alone, The hardest part about committing to gym memberships is ...
(Date:6/3/2015)... Come on out in support of the ... beginning in Madison, Wisconsin on Friday, June 12th and ... For the 4th consecutive year, a very dedicated group ... money for the Brain Aneurysm Foundation. , The 12-member ... staff from The University of Illinois Medical Center, including ...
Breaking Medicine News(10 mins):Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3Health News:4th Annual Ragnar Relay from Madison, WI to Chicago, IL Once Again Benefits Renowned Brain Aneurysm Foundation 2
... center, a tuberculosis case alerts the health authorities //. ... worker, who works at the Centenary Childcare and Early ... ,Dr Michael Whitby, a spokesman of Australian Medical ... the center are at risk of getting infected. ...
... Deadly H5N1 virus is been brought into New Zealand by ... ,At Wallaceville, country's highest security laboratory holds the threatening substance ... ,Joseph O'Keefe, the Wallaceville manager said it ... was kept inside a freezer. Well-trained staffs, wearing safe suits ...
... a research it was found that older people do not ... //. Their brain activity softens over a period of time. ... of 12-79 by using brain imaging techniques. Emotional stability was ... life. They were also comparatively less neurotic than teenagers. The ...
... A controversial set of laws was initiated by Quebec Health ... option of private health-care insurance //. ,The Supreme ... on private insurance, on June 9, 2005,ruling that Quebec had ... acts covered by medicare, was justified. However with the ...
... is being misused by some men to prevent the growth ... , bodybuilders , who resort to excessive use of steroids in ... abusing anti- cancer drugs like tamoxifen, to prevent breast ... steroids. Although derived from testosterone, an increased level of steroids in the ...
... have warned of another outbreak of bird flu in Maharashtra ... culled// in the first episode of the dreaded virus outbreak ... bird flu in the Nandurbar and Jalgaon regions, giving a ... ,If experts of the technical committee set up by ...
Cached Medicine News:Health News:Quebecers To Choose Private Health-Care Insurance 2Health News:Experts Warn of Bird Flu Recurrence in Maharashtra 2
... benchtop ductless exhaust hood ventilates and ... indoor release of exhaust. Bonded charcoal ... 28" of vertical clearance (with access ... polypropylene spill tray; options include final ...
... spot fume hood mounts on a standard ... 12.7mm (10" x 1/2" ) mounting rod. ... is placed above the source of fumes. ... tubing which connects to an aspirator or ...
This fume hood features a one-piece shell molded of polyethylene with a clear acrylic panel that slides on inside tracks. It can be set in an open, closed or intermediate position....
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
Medicine Products: